| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Rocuronium Bromide EP Impurity C |
羅庫(kù)溴銨EP雜質(zhì)C |
119302-86-2 |
詳細(xì)
|
| Rocuronium Bromide EP Impurity B |
羅庫(kù)溴銨EP雜質(zhì)B |
122483-73-2 |
詳細(xì)
|
| Aprepitant EP Impurity C |
阿瑞匹坦EP雜質(zhì)C |
2348441-63-2 |
詳細(xì)
|
| Rocuronium Bromide EP Impurity D |
羅庫(kù)溴銨EP雜質(zhì)D |
1190105-63-5 |
詳細(xì)
|
| N-((S)-10-formyl-5,6,7,8-tetrahydro-pteroyl)-L-glutamic acid |
|
74644-66-9 |
詳細(xì)
|
| 3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile |
3-環(huán)戊基-3-[4-(4,4,5,5-四甲基-1,3,2-二氧雜硼烷-2-基)-1H-吡唑-1-基]丙腈 |
1153949-38-2 |
詳細(xì)
|
| 2-Oxa-8-azaspiro[4.5]decan-4-amine, 3-methyl-, hydrochloride (1:2), (3S,4S)- |
(3S,4S)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine dihydrochloride
英文 |
2055761-19-6 |
詳細(xì)
|
| (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
(4-氯-7H-吡咯并[2,3-D]嘧啶-7-基)甲基特戊酸酯 |
1146629-75-5 |
詳細(xì)
|
| Calcitriol EP Impurity A |
骨化三醇EP雜質(zhì)A |
73837-24-8 |
詳細(xì)
|
| Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) |
9-(4-甲氧基-2,3,6-三甲基苯基)-3,7-二甲基-2,4,6,8-丁烯酸 |
69427-46-9 |
詳細(xì)
|
| Tedizolid Ring Open Impurity |
特地唑胺異構(gòu)體雜質(zhì) |
1239662-49-7 |
詳細(xì)
|
| (5R)-3-[4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone |
特地唑胺雜質(zhì) |
1256966-04-7 |
詳細(xì)
|
| (R)-(3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-2- oxooxazolidin-5-yl)methyl dihydrogen phosphate |
特地唑胺雜質(zhì)09 |
1239662-47-5 |
詳細(xì)
|
| (R)-3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-5- (hydroxymethyl)oxazolidin-2-one |
特地唑胺雜質(zhì)08 |
1771765-84-4 |
詳細(xì)
|
| bis(((R)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl) hydrogen phosphate |
特地唑胺雜質(zhì)37 |
1256966-02-5 |
詳細(xì)
|
| Azilsartan Impurity H |
阿齊沙坦雜質(zhì)H |
1499167-72-4 |
詳細(xì)
|
| Azilsartan Impurity 37 |
阿齊沙坦雜質(zhì)37 |
147404-76-0 |
詳細(xì)
|
| Methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate |
2-[[(2'-氰基聯(lián)苯-4-基)甲基]氨基]-3-硝基苯甲酸甲酯 |
139481-28-0 |
詳細(xì)
|
| Azilsartan Impurity D |
阿奇沙坦雜質(zhì)D |
1821386-21-3 |
詳細(xì)
|
| Azilsartan Impurity K |
阿齊沙坦雜質(zhì) K |
1442400-68-1 |
詳細(xì)
|
| Azilsartan Impurity O |
阿齊沙坦雜質(zhì)O |
2171316-29-1 |
詳細(xì)
|
| Azilsartan Impurity 52 |
阿齊沙坦雜質(zhì) 52 |
139481-38-2 |
詳細(xì)
|
| Azilsartan Impurity C |
阿齊沙坦雜質(zhì)C |
1397836-49-5 |
詳細(xì)
|
| NA |
|
16963392-11-6 |
詳細(xì)
|
| Azilsartan Impurity 45 |
阿齊沙坦雜質(zhì)45 |
136304-78-4 |
詳細(xì)
|
| Azilsartan Impurity I |
阿齊沙坦雜質(zhì)I |
139481-33-7 |
詳細(xì)
|
| Azilsartan Impurity 3 |
阿齊沙坦雜質(zhì)3 |
1696392-12-7 |
詳細(xì)
|
| Azilsartan Impurity N |
阿齊沙坦雜質(zhì)N |
2244031-86-3 |
詳細(xì)
|
| Azilsartan Impurity M |
阿齊沙坦雜質(zhì)M |
632322-61-3 |
詳細(xì)
|
| Azilsartan |
阿齊沙坦 |
147403-03-0 |
詳細(xì)
|
| Azilsartan Impurity I |
阿齊沙坦雜質(zhì)I |
1403474-78-1 |
詳細(xì)
|
| (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide |
利伐沙班雜質(zhì)I |
721401-53-2 |
詳細(xì)
|
| Folic Acid EP Impurity H |
葉酸EP雜質(zhì)H |
2366274-27-1 |
詳細(xì)
|
| Iguratimod Impurity |
艾拉莫德雜質(zhì) |
149436-41-9 |
詳細(xì)
|
| Iguratimod Impurity |
艾拉莫德雜質(zhì) |
149457-03-4 |
詳細(xì)
|
| Iguratimod Impurity |
艾拉莫德雜質(zhì) |
123662-92-0 |
詳細(xì)
|
| Iguratimod Impurity |
艾拉莫德雜質(zhì) |
123663-48-9 |
詳細(xì)
|
| Iguratimod Impurity |
艾拉莫德雜質(zhì) |
1179354-65-4 |
詳細(xì)
|
| Ruxolitinib Impurity 17 |
蘆可替尼雜質(zhì)17 |
2950130-23-9 |
詳細(xì)
|
| Vecuronium Bromide Impurity 4 |
維庫(kù)溴銨雜質(zhì)H |
13522-24-2 |
詳細(xì)
|
| (2β,3α,5α,16β,17β)-2,16-Di-(1-piperidinyl)androstane-3,17-diol 3-Acetate |
維庫(kù)溴銨雜質(zhì)I |
53357-31-6 |
詳細(xì)
|
| Dolutegravir Impurity 3 |
度魯特韋雜質(zhì) 3 |
1973402-05-9 |
詳細(xì)
|
| Dolutegravir Impurity 11 |
度魯特韋雜質(zhì)27 |
2227442-13-7 |
詳細(xì)
|
| Dolutegravir Impurity 10 |
多替拉韋雜質(zhì)10 |
1863916-87-3 |
詳細(xì)
|
| Dolutegravir Impurity 9 |
多替拉韋雜質(zhì)9 |
1863916-88-4 |
詳細(xì)
|
| Dolutegravir Impurity 16 |
多替拉韋雜質(zhì)16 |
1357289-37-2 |
詳細(xì)
|
| Dolutegravir (S,R)-Isomer |
多替拉韋雜質(zhì)7 |
1309560-49-3 |
詳細(xì)
|
| Dolutegravir Impurity 8 |
多替拉韋雜質(zhì)8 |
2244161-72-4 |
詳細(xì)
|
| Dolutegravir Impurity 6 |
多替拉韋雜質(zhì)6 |
1357289-29-2 |
詳細(xì)
|
| Dolutegravir Impurity 11 |
多替拉韋雜質(zhì)11 |
2244161-71-3 |
詳細(xì)
|
| Folic Acid EP Impurity F |
葉酸EP雜質(zhì)F |
1391194-56-1 |
詳細(xì)
|
| cis-Haloperidol N-Oxide |
順式-氟哌啶醇氮氧化物 |
150214-94-1 |
詳細(xì)
|
| trans-Bilastine N-Oxide |
反式-比拉斯汀氮氧化物 |
1934257-94-9 |
詳細(xì)
|
| Trans-Haloperidol N-Oxide |
反式-氟哌啶醇氮氧化物 |
150214-93-0 |
詳細(xì)
|
| cis-Bilastine N-Oxide |
順式-比拉斯汀氮氧化物 |
1934257-95-0 |
詳細(xì)
|
| N-((3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-5-oxotetrahydrofuran-3-yl)methyl)ethanesulfonamide |
巴瑞替尼內(nèi)脂雜質(zhì) |
2910813-43-1 |
詳細(xì)
|
| Vitamin K1 impurity 1 |
維生素K1雜質(zhì)1 |
220904-29-0 |
詳細(xì)
|
| Vitamin K1 impurity 2 |
維生素K1雜質(zhì)2 |
107438-44-8 |
詳細(xì)
|
| Vitamin K1 impurity 3 |
維生素K1雜質(zhì)3 |
127951-70-6 |
詳細(xì)
|